Foreign-born women of reproductive age living in the US have lower hepatitis B virus (HBV) vaccination and screening coverage than their US-born counterparts and screening for HBV is underutilized, a recent report suggests. Researchers pooled data from the National Health Interview Survey 2013-2015 to estimated prevalence of lifetime history of HBV vaccination and screening self-reported to women aged 18 to 44 years who were born in the US or elsewhere. They found:
- Among women of reproductive age (n=24,216), reported HBV vaccination was 33% lower for foreign-born (27.3%) than US-born (40.9%) women.
- Vaccination coverage was low for women born in Mexico and other parts of Central America.
- Factors association with vaccination in both groups included education, income, and health insurance coverage.
- Screening was reported by 28.5% of foreign-born vs 31.9% of US-born women.
Kilmer GA, Barker LK, Ly KN, Jiles RB. Hepatitis B vaccination and screening among foreign-born women of reproductive age in the United States: 2013-2015. [Published online ahead of print June 1, 2018]. Clin Infect Dis. doi:10.1093/cid/ciy479.